SU638252A3 - Способ получени производных аминоэтанола или их солей - Google Patents

Способ получени производных аминоэтанола или их солей

Info

Publication number
SU638252A3
SU638252A3 SU762402852A SU2402852A SU638252A3 SU 638252 A3 SU638252 A3 SU 638252A3 SU 762402852 A SU762402852 A SU 762402852A SU 2402852 A SU2402852 A SU 2402852A SU 638252 A3 SU638252 A3 SU 638252A3
Authority
SU
USSR - Soviet Union
Prior art keywords
group
amino
carbon atoms
theory
salts
Prior art date
Application number
SU762402852A
Other languages
English (en)
Russian (ru)
Inventor
Айк Свенссон Лейф
Магнус Серенби Ларс
Ингвар Леопольд Веттерлин Чель
Original Assignee
Актиеболагет Драко (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Актиеболагет Драко (Фирма) filed Critical Актиеболагет Драко (Фирма)
Application granted granted Critical
Publication of SU638252A3 publication Critical patent/SU638252A3/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/04Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reaction of ammonia or amines with olefin oxides or halohydrins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/321,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SU762402852A 1975-10-01 1976-09-22 Способ получени производных аминоэтанола или их солей SU638252A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7510988A SE7510988L (sv) 1975-10-01 1975-10-01 Nya farmaceutiskt aktiva foreningar

Publications (1)

Publication Number Publication Date
SU638252A3 true SU638252A3 (ru) 1978-12-15

Family

ID=20325688

Family Applications (2)

Application Number Title Priority Date Filing Date
SU762402852A SU638252A3 (ru) 1975-10-01 1976-09-22 Способ получени производных аминоэтанола или их солей
SU772532454A SU674669A3 (ru) 1975-10-01 1977-10-13 Способ получени производных этанола или их солей

Family Applications After (1)

Application Number Title Priority Date Filing Date
SU772532454A SU674669A3 (ru) 1975-10-01 1977-10-13 Способ получени производных этанола или их солей

Country Status (19)

Country Link
JP (1) JPS5242840A (enExample)
AT (1) AT347427B (enExample)
AU (1) AU503212B2 (enExample)
BE (1) BE846837A (enExample)
CS (2) CS199643B2 (enExample)
DD (1) DD126278A5 (enExample)
DE (1) DE2640972A1 (enExample)
DK (1) DK141622B (enExample)
ES (1) ES451979A1 (enExample)
FI (1) FI762660A7 (enExample)
FR (1) FR2326183A1 (enExample)
GB (1) GB1542317A (enExample)
LU (1) LU75916A1 (enExample)
NL (1) NL7610845A (enExample)
NO (1) NO763345L (enExample)
NZ (1) NZ182165A (enExample)
SE (1) SE7510988L (enExample)
SU (2) SU638252A3 (enExample)
ZA (1) ZA765331B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1273A (en) 1980-07-09 1985-03-08 Draco Ab 1-(dihydroxyphenyl)-2-amino-ethanol derivatives;preparation,compositions and intermediates
EP0103830A3 (de) * 1982-09-22 1985-07-31 Bayer Ag Wachstumsfördernde Phenylethylamin-Derivate
IL121625A (en) * 1995-12-28 2001-09-13 Welfide Corp Preparation containing 2 - amino - 2 - (-2 (-4-octylphenyl) ethyl) propane - 1, 3, - dial for local topical use
EP2332921B1 (en) 2003-06-17 2016-03-02 Arena Pharmaceuticals, Inc. 8-Chloro-1 -methyl-2,3,4,5-tetrahydro-1 H-3benzazapine Hydrochloride
CN101466684B (zh) 2006-04-03 2012-06-20 艾尼纳制药公司 8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓的制备工艺和其相关中间体
CA2670285A1 (en) 2006-12-05 2008-06-12 Arena Pharmaceuticals, Inc. Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
RU2361604C1 (ru) * 2007-10-29 2009-07-20 Федеральное агентство по высокотехнологичной медицинской помощи Федеральное государственное учреждение "Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии" (ФГУ УрНИИДВиИ Росмедтехнологий) Способ лечения атопического дерматита
EP2288585A1 (en) 2008-03-04 2011-03-02 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-ht2c agonist (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine
EP2443080A2 (en) 2009-06-18 2012-04-25 Arena Pharmaceuticals, Inc. Process for the preparation of 5-ht2c receptor agonists
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
WO2012030939A1 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Administration of lorcaserin to individuals with renal impairment
KR20130138770A (ko) 2010-09-01 2013-12-19 아레나 파마슈티칼스, 인크. 광학적으로 활성 산을 갖는 로르카세린의 염
EP2611433A2 (en) 2010-09-01 2013-07-10 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-ht2c agonists
EP3485878A1 (en) 2010-09-01 2019-05-22 Arena Pharmaceuticals, Inc. Modified-release dosage forms of 5-ht2c agonists useful for weight management
JP2015534563A (ja) 2012-10-09 2015-12-03 アリーナ ファーマシューティカルズ, インコーポレイテッド 体重管理の方法

Also Published As

Publication number Publication date
NL7610845A (nl) 1977-04-05
ATA682376A (de) 1978-05-15
LU75916A1 (enExample) 1978-05-16
AU503212B2 (en) 1979-08-30
BE846837A (fr) 1977-04-01
GB1542317A (en) 1979-03-14
DD126278A5 (enExample) 1977-07-06
NZ182165A (en) 1978-07-10
FR2326183A1 (fr) 1977-04-29
DK439776A (enExample) 1977-04-02
DK141622B (da) 1980-05-12
AT347427B (de) 1978-12-27
JPS5242840A (en) 1977-04-04
AU1812276A (en) 1978-04-06
DE2640972A1 (de) 1977-04-14
FI762660A7 (enExample) 1977-04-02
ZA765331B (en) 1977-08-31
CS199644B2 (en) 1980-07-31
CS199643B2 (en) 1980-07-31
NO763345L (enExample) 1977-04-04
ES451979A1 (es) 1978-01-01
SU674669A3 (ru) 1979-07-15
SE7510988L (sv) 1977-04-02

Similar Documents

Publication Publication Date Title
SU638252A3 (ru) Способ получени производных аминоэтанола или их солей
SU867298A3 (ru) Способ получени производных пиперидина или их солей
BG63661B2 (bg) Производно на 3-амино-1-пропенон
SU510999A3 (ru) Способ получени (метоксиметил-фурилметил)6,7-бензоморфанов илиморфинанов
SU578883A3 (ru) Способ получени пиразолоизохинолинов или их солей
US4403096A (en) Optically active imidazolidin-2-one derivatives
SU481155A3 (ru) Способ получени -(фурил-метил)морфинанов
US3687967A (en) {60 -dehydrobiotin synthesis
SU508176A3 (ru) Способ получени аминопроизводных бензофенона
SU786895A3 (ru) Способ получени производных тиазолидин-,тиазан-или морфолинкарбоновых кислот или их кислотно-аддитивных солей
US4317920A (en) Arylacetic acid derivatives
SU535899A3 (ru) Способ получени -(1-бисарилалкиламиноалкил)-аралкоксибензиловых спиртов или их солей, рацематов или оптически активных антиподов
SU803859A3 (ru) Способ получени -тиопропионами-дОВ или иХ КиСлОТНО-АддиТиВНыХСОлЕй
SU1128831A3 (ru) Способ получени производных аминоэтанола или их солей
SU586840A3 (ru) Способ получени производных 1,4-бензодиоксана
US4537906A (en) Substituted phenylalkenoic acids and esters
SU670216A3 (ru) Способ получени производных оксима или их солей
SU731889A3 (ru) Способ получени производных бензилфенилкетона
SU862822A3 (ru) Способ получени N-циано-N -метил-N 2 @ /4-метил-5-имидазолил/-метилтио @ -этил @ гуанидина
SU482039A3 (ru) Способ получени бифенилилбутеновых кислот или их производных
SU650502A3 (ru) Способ получени 4-(4"-хлорбензилокси)-бензилникотината или его солей
SU503508A3 (ru) Способ получени -бис/ -оксиарилэтил- диаминоалканов
US4465855A (en) Process for the preparation of arylacetic acid derivatives
SU869556A3 (ru) Способ получени 2-(ацетилсалицилокси)-1,3-ди-(п-хлорфенокси-2-метил-пропаноилокси)-пропана
SU722480A3 (ru) Способ получени -аминоалкоксициклоалканов или их солей